DK3016673T3 - Pattedyrsmælkeosteopontin til forbedring af immunreaktion - Google Patents
Pattedyrsmælkeosteopontin til forbedring af immunreaktionInfo
- Publication number
- DK3016673T3 DK3016673T3 DK14735964.0T DK14735964T DK3016673T3 DK 3016673 T3 DK3016673 T3 DK 3016673T3 DK 14735964 T DK14735964 T DK 14735964T DK 3016673 T3 DK3016673 T3 DK 3016673T3
- Authority
- DK
- Denmark
- Prior art keywords
- mammalian milk
- mammal
- infectious disease
- milk osteopontin
- active
- Prior art date
Links
- 102000004264 Osteopontin Human genes 0.000 title abstract 4
- 108010081689 Osteopontin Proteins 0.000 title abstract 4
- 239000008267 milk Substances 0.000 title abstract 4
- 210000004080 milk Anatomy 0.000 title abstract 4
- 235000013336 milk Nutrition 0.000 title abstract 4
- 230000028993 immune response Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 5
- 208000035473 Communicable disease Diseases 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 230000004043 responsiveness Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 | ||
| PCT/EP2014/064339 WO2015001092A1 (en) | 2013-07-05 | 2014-07-04 | Mammalian milk osteopontin for enhancing immune responsiveness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3016673T3 true DK3016673T3 (da) | 2018-01-29 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14735964.0T DK3016673T3 (da) | 2013-07-05 | 2014-07-04 | Pattedyrsmælkeosteopontin til forbedring af immunreaktion |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9956283B2 (da) |
| EP (1) | EP3016673B1 (da) |
| JP (1) | JP6509833B2 (da) |
| KR (1) | KR102307002B1 (da) |
| CN (1) | CN105407910B (da) |
| AU (1) | AU2014286123B2 (da) |
| BR (1) | BR112016000067B1 (da) |
| CA (1) | CA2916821C (da) |
| CL (1) | CL2015003803A1 (da) |
| DK (1) | DK3016673T3 (da) |
| EA (1) | EA034654B1 (da) |
| ES (1) | ES2656474T3 (da) |
| MX (1) | MX369925B (da) |
| NZ (1) | NZ715430A (da) |
| PH (1) | PH12015502844B1 (da) |
| PL (1) | PL3016673T3 (da) |
| PT (1) | PT3016673T (da) |
| WO (1) | WO2015001092A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202009574RA (en) * | 2018-04-25 | 2020-10-29 | Health And Happiness H&H Hong Kong Ltd | Combinations of osteopontin and 2'-fucosyllactose for use as medicaments |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| WO2023144416A1 (en) * | 2022-01-31 | 2023-08-03 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) * | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| CA2293492A1 (en) * | 1997-06-11 | 1998-12-17 | Martin Berry | Cns neuroregenerative compositions and methods of use |
| IL145891A0 (en) * | 1999-04-15 | 2002-07-25 | Childrens Medical Center | Methods and compositions for modulating an immune response |
| ATE324378T1 (de) | 2000-01-07 | 2006-05-15 | Arla Foods Amba | Verfahren zur isolierung von osteopontin aus milch |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| AU2003239589A1 (en) * | 2002-05-24 | 2003-12-12 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| DK1667537T3 (da) * | 2003-09-18 | 2014-01-27 | Arla Foods Amba | Modermælkserstatning |
| RU2379975C2 (ru) | 2003-09-18 | 2010-01-27 | Арла Фудс Амба | Добавка в состав для детского питания |
| KR20090123115A (ko) * | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| MX2013010017A (es) * | 2011-03-03 | 2014-08-01 | Arla Foods Amba | Metodo para aislamiento de osteopontina utilizando alimentos que contienen especies de cmp o caseina. |
| BR112014013565A2 (pt) | 2011-12-07 | 2019-09-24 | Arla Foods Amba | variante da opn para uso no tratamento ou prevenção de câncer envolvendo pelo menos um tumor canceroso, método de tratamento ou prevenção do câncer, composição farmacêutica e suplemento nutricional |
-
2014
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en active Application Filing
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active IP Right Grant
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844B1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015001092A1 (en) | 2015-01-08 |
| CL2015003803A1 (es) | 2016-08-05 |
| CA2916821C (en) | 2023-10-03 |
| PH12015502844A1 (en) | 2016-03-28 |
| CN105407910A (zh) | 2016-03-16 |
| EA034654B1 (ru) | 2020-03-03 |
| BR112016000067A2 (da) | 2017-09-05 |
| KR20160030960A (ko) | 2016-03-21 |
| CN105407910B (zh) | 2019-12-03 |
| US20160136268A1 (en) | 2016-05-19 |
| EA201690057A1 (ru) | 2016-07-29 |
| PT3016673T (pt) | 2018-01-30 |
| ES2656474T3 (es) | 2018-02-27 |
| US20180289798A1 (en) | 2018-10-11 |
| US9956283B2 (en) | 2018-05-01 |
| JP6509833B2 (ja) | 2019-05-08 |
| EP3016673A1 (en) | 2016-05-11 |
| KR102307002B1 (ko) | 2021-10-05 |
| MX2016000107A (es) | 2016-06-07 |
| BR112016000067B1 (pt) | 2022-08-30 |
| PH12015502844B1 (en) | 2016-03-28 |
| MX369925B (es) | 2019-11-25 |
| PL3016673T3 (pl) | 2018-04-30 |
| JP2016529217A (ja) | 2016-09-23 |
| AU2014286123B2 (en) | 2019-02-28 |
| AU2014286123A1 (en) | 2016-01-21 |
| CA2916821A1 (en) | 2015-01-08 |
| US10772955B2 (en) | 2020-09-15 |
| EP3016673B1 (en) | 2017-10-25 |
| NZ715430A (en) | 2022-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
| EA201391597A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
| WO2015168379A3 (en) | Combination vaccine devices and methods of killing cancer cells | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| BR112013012555A2 (pt) | peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes | |
| EP4272750A3 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
| EA201891124A3 (ru) | Новые мукозные адъюванты и системы доставки | |
| EA201790507A1 (ru) | Способы и композиции для усиления иммунных ответов | |
| PH12015502844B1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
| CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
| BR112016015422A2 (pt) | formulações de vacina de frasco único | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| PH12015501716B1 (en) | Anti-mycoplasma spp. subunit vaccine | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| WO2013188627A3 (en) | Cationic lipid vaccine compositions and methods of use | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| BR112014020025A2 (pt) | vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
| WO2014140166A3 (en) | Vaccine | |
| NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| IN2014DN09445A (da) | ||
| WO2017053525A3 (en) | Influenza vaccine and therapy | |
| WO2011084967A3 (en) | Methods and compositions for providing protective immunity in the elderly | |
| WO2013173256A3 (en) | New and improved influenza vaccines |